Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

THE US GRANT, a Luxury Collection Hotel, San Diego

Nov 10, 2022 7:00 AM - Nov 11, 2022 12:30 PM

326 Broadway, San Diego, CA 92101

Real-World Evidence Conference

Translating Insights into Real-World Value

Session 4: Evolving the Clinical Trial Landscape Using Real-World Data

Session Chair(s)

Brad  Jordan, PhD

Brad Jordan, PhD

Associate Vice President, Regulatory Policy and Strategy

Eli Lilly and Company, United States

Mark  Stewart, PhD

Mark Stewart, PhD

Vice President, Science Policy

Friends of Cancer Research, United States

The past several years has seen a necessary evolution in how clinical research is performed. At the forefront of this is the utilization of real-world data to inform clinical trial design, develop diversity plans, and facilitate the conduct of clinical trials at the point of care. This session will examine the present and future contribution of RWD and highlight important efforts and case study examples aimed at using RWD to contribute to the transformation of clinical research and clinical trial design for improved regulatory and health care decision-making.

Learning Objective : At the conclusion of this session, participants will:
  • Recognize how real-world data can be used to assist in study design and as a data source to facilitate clinical research
  • Apply lessons learned and strategies from recent efforts and case studies to support clinical research and trial designs
  • Understand experiences to date and identify practical and technological considerations to further implement real-world clinical research


Raymond  Harvey, MPH

Real-World Data Applications With Clinical Trials

Raymond Harvey, MPH

Janssen Pharmaceutical Companies of Johnson & Johnson, United States

Senior Director, Data Science

Kraig  Kinchen, MD, MS

What Role Should Point-Of-Care Trials Play In Leveraging RWD?

Kraig Kinchen, MD, MS

Eli Lilly and Company, United States

Associate Vice President, Value, Evidence, and Outcomes, Diabetes Business Unit

Rachele  Hendricks-Sturrup, DrSc, MA, MSc

An Update On The State Of Real-World Evidence Policy

Rachele Hendricks-Sturrup, DrSc, MA, MSc

Duke-Robert J. Margolis, MD, Center for Health Policy, United States

Research Director, Real-World Evidence

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.